Suppr超能文献

上半身中心静脉阻塞的血管内治疗

Endovascular Treatment for Upper Body Central Venous Obstruction.

作者信息

Miyayama Shiro, Yamashiro Masashi, Ikeda Rie, Yokka Akira, Fujita Takeo, Sakuragawa Naoko

机构信息

Department of Diagnostic Radiology, Fukui-ken Saiseikai Hospital, Japan.

出版信息

Interv Radiol (Higashimatsuyama). 2024 Nov 22;10:e20230043. doi: 10.22575/interventionalradiology.2023-0043. eCollection 2025 Mar 28.

Abstract

Endovascular treatment, such as catheter-directed thrombolysis, thrombectomy, balloon angioplasty, and metallic stent placement, is performed for symptomatic upper body central venous obstruction caused by both malignant and benign etiologies. In particular, metallic stent placement should be performed in emergent situations for malignant superior vena cava syndrome presenting with cerebral or laryngeal edema. In malignant cases, the obstruction is usually traversed via the femoral vein. When it fails, an additional trial via the brachial or internal jugular vein is performed, and if necessary, through-and-through access is established. In benign chronic obstructions that cannot be crossed by conventional techniques, sharp recanalization techniques are salvage options. The procedures are relatively safe; however, major complications such as acute pulmonary edema, cardiac tamponade, pulmonary embolism, and stent migration should be warned.

摘要

血管内治疗,如导管定向溶栓、血栓切除术、球囊血管成形术和金属支架置入术,用于治疗由恶性和良性病因引起的有症状的上半身中心静脉阻塞。特别是,对于出现脑或喉水肿的恶性上腔静脉综合征,应在紧急情况下进行金属支架置入术。在恶性病例中,梗阻通常通过股静脉穿过。如果失败,则通过肱静脉或颈内静脉进行额外尝试,必要时建立贯穿入路。对于常规技术无法穿过的良性慢性梗阻,锐性再通技术是挽救选择。这些操作相对安全;然而,应警惕急性肺水肿、心脏压塞、肺栓塞和支架移位等主要并发症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a404/12078050/6be9133f4399/2432-0935-10-e2023-0043-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验